Gabapentine

ApprovedSmall molecule

AAssistance Publique - Hôpitaux de Paris

Gabapentine is one of 38 small molecule programs targeting Bruxism. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

BruxismActive, not recruiting

Herpes ZosterActive, not recruiting

BruxismPreclinical

Active, not recruiting

Herpes ZosterApproved

Active, not recruiting

Competition

Competitive Landscape

92 competitors in Herpes Zoster

#DrugCompanyPhaseTrials

Fluzone

Sanofi

Phase 3

—2

Herpes Zoster Vaccine 1437173a

GSK

Phase 3

18 3

GSK 257049

GSK

Phase 3

1 4

Rsvpref3 Vaccine

GSK

Phase 3

1 5

Boostrix

GSK

Phase 3

1 6

Prevenar13

GSK

Phase 3

1 7

Valtrex

GGlaxo Dba Glaxosmithkline

Phase 2

4 8

Gabapentine

AAssistance Publique - Hôpitaux de Paris

Approved

1 9

Hz/su VACCINE

GSK

Phase 3

5 10

Valaciclovir

GSK

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pediatrics1 trial

Population Pharmacokinetics of Antiepileptic in Pediatrics

Completed·AAssistance Publique - Hôpitaux de Paris··NCT03196466·753 enrolled

Herpes Zoster1 trial

Acupuncture in Herpes Zoster Neuralgia (ACUZoster)

Completed·DDominik Irnich·Phase 4·NCT00885586·68 enrolled

Preoperative1 trial

Preoperative Gabapentine for Carpal Tunnel

Completed·FFederal University of São Paulo·Phase 3·NCT01632215·40 enrolled

Bruxism1 trial

Comparative Evaluation of Gabapentine and Occlusal Splint in the Management of Sleep Bruxism

Completed·MMashhad University of Medical Sciences·N/A·NCT01255878·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Gabapentine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gabapentine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gabapentine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: AAssistance Publique - Hôpitaux de Paris

Gabapentine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pediatrics1 trial

Herpes Zoster1 trial

Preoperative1 trial

Bruxism1 trial

References

Drug Info

Quick Facts

Related News